Winton Group LTD Castle Biosciences Inc Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$39.06 - $67.58 $179,949 - $311,341	-4,607 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$60.13 - $77.6 $28,802 - $37,170	479 Added 11.6%	4,607 $306,000
Q2 2021 Aug 10, 2021	BUY	$50.07 - $76.78 $1,301 - $1,996	26 Added 0.63%	4,128 $303,000
Q1 2021 Jul 21, 2021	SELL	$58.92 - $97.33 $143,764 - $237,485	-2,440 Reduced 37.3%	4,102 $281,000
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $46,085 - $77,213	1,057 Added 19.27%	6,542 $439,000

Q3 2020 Oct 30, 2020	BUY	$38.47 - $52.03 $211,007 - $285,384	5,485 New	5,485 $282,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.